Trial Outcomes & Findings for Monetary Cost of Alzheimer's Disease in China (NCT NCT02694445)

Results Overview

The annual national total socioeconomic cost for all patients with AD in China in 2015 was obtained, with the average annual cost per patient with AD from our results multiplied by the all number of patients with AD in 2015. So, the value reported in the data table below represents the total cost for all all participants in China.

Recruitment status

COMPLETED

Target enrollment

3098 participants

Primary outcome timeframe

one year

Results posted on

2020-05-12

Participant Flow

Participant milestones

Participant milestones
Measure	Participant Patients Patient aged ≥60 years, inclusion criteria were: (1) a primary diagnosis of AD according to the National Institute of Neurologic and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria, 13 diagnosed by a dementia specialist; (2) complete information about the economic costs of AD and comorbidities, obtained from electronic medical records systems and face-to-face interviews; and (3) no co-morbidity with direct medical cost \> 10% of the total annual costs due to AD.
Overall Study STARTED	3098
Overall Study COMPLETED	3046
Overall Study NOT COMPLETED	52

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure	Participant Patients n=3046 Participants Patient aged ≥60 years, inclusion criteria were: (1) a primary diagnosis of AD according to the National Institute of Neurologic and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria, 13 diagnosed by a dementia specialist; (2) complete information about the economic costs of AD and comorbidities, obtained from electronic medical records systems and face-to-face interviews; and (3) no co-morbidity with direct medical cost \> 10% of the total annual costs due to AD.
Age, Continuous	75.24 years STANDARD_DEVIATION 9.43 • n=3046 Participants
Sex: Female, Male Female	1651 Participants n=3046 Participants
Sex: Female, Male Male	1395 Participants n=3046 Participants
Region of Enrollment China	3046 participants n=3046 Participants

PRIMARY outcome

Timeframe: one year

The annual national total socioeconomic cost for all patients with AD in China in 2015 was obtained, with the average annual cost per patient with AD from our results multiplied by the all number of patients with AD in 2015. So, the value reported in the data table below represents the total cost for all all participants in China.

Outcome measures

Outcome measures
Measure	Participant AD Patients n=3046 Participants Patient aged ≥60 years, inclusion criteria were: (1) a primary diagnosis of AD according to the National Institute of Neurologic and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (NINCDS-ADRDA) criteria, 13 diagnosed by a dementia specialist; (2) complete information about the economic costs of AD and comorbidities, obtained from electronic medical records systems and face-to-face interviews; and (3) no co-morbidity with direct medical cost \> 10% of the total annual costs due to AD.
The Annual National Total Socioeconomic Cost for All AD Patients in China	167.74 billion US$

Adverse Events

Participant Patients

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Jianping Jia

Department of Neurology, Xuan Wu Hospital,Beijing,China

Phone: 010-63150669

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place